Detalles de la búsqueda
1.
The Regions on the Light Chain of Botulinum Neurotoxin Type A Recognized by T Cells from Toxin-Treated Cervical Dystonia Patients. The Complete Human T-Cell Recognition Map of the Toxin Molecule.
Immunol Invest
; 47(1): 18-39, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28891721
2.
Targeting the antigen-binding site of HLA-restricting alleles in treatment of autoimmune disease.
Crit Rev Immunol
; 27(3): 271-88, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18197821
3.
Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule.
Immunol Lett
; 190: 257-264, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28823519
4.
Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
Autoimmunity
; 50(5): 293-305, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28548588
5.
Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
Autoimmunity
; 50(6): 346-353, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28850269
6.
Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules.
J Neuroimmunol
; 306: 31-39, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28385185
7.
Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice.
J Neuroimmunol
; 171(1-2): 8-16, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16271400
8.
Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK).
J Neuroimmunol
; 175(1-2): 107-17, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16697051
9.
Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis.
Autoimmunity
; 39(4): 277-88, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16891216
10.
Submolecular recognition regions of the HN domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
J Neuroimmunol
; 300: 36-46, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806874
11.
Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients.
Immunobiology
; 221(4): 568-76, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26701846
12.
Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity.
Hum Immunol
; 66(1): 32-42, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15620460
13.
Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients.
Autoimmunity
; 38(2): 161-9, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16040337
14.
Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG.
Autoimmunity
; 35(3): 183-90, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12389643
15.
Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB/c mice primed with inactivated toxin.
Immunobiology
; 219(12): 950-7, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25151501
16.
T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
Autoimmunity
; 45(2): 153-60, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21985279
17.
Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains.
Immunobiology
; 217(1): 1-7, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22015045
18.
Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans.
Autoimmunity
; 44(3): 167-76, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20843162
19.
Human T-cell responses to botulinum neurotoxin: proliferative responses in vitro of lymphocytes from botulinum neurotoxin A-treated movement disorder patients.
J Neuroimmunol
; 237(1-2): 66-72, 2011 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21737146
20.
Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B.
J Neuroimmunol
; 240-241: 121-8, 2011 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22079193